vTv Therapeautics TTP488-301

Drug Development Trials

About the trial

Randomized, double-blind, placebo-controlled, multi-center registration trial to evaluate the efficacy and safety of TTP488 in patients with mild Alzheimer’s disease receiving acetylcholinesterase inhibitors and/or memantine

View study